Zevia PBC (NYSE:ZVIA – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.07), Zacks reports. Zevia PBC had a negative return on equity of 38.02% and a negative net margin of 14.02%. Zevia PBC updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.
Zevia PBC Stock Down 28.3 %
Shares of NYSE:ZVIA traded down $0.92 during trading on Wednesday, reaching $2.34. 1,168,288 shares of the company traded hands, compared to its average volume of 777,743. The firm has a market capitalization of $170.63 million, a PE ratio of -6.07 and a beta of 0.65. Zevia PBC has a 52 week low of $0.62 and a 52 week high of $4.99. The company’s 50 day moving average is $3.91 and its two-hundred day moving average is $2.36.
Insider Buying and Selling
In other Zevia PBC news, Director Rosemary L. Ripley sold 2,567,006 shares of the stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $1.90, for a total transaction of $4,877,311.40. Following the sale, the director now directly owns 2,719,258 shares in the company, valued at $5,166,590.20. This represents a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Amy Taylor sold 11,479 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $4.74, for a total transaction of $54,410.46. Following the completion of the transaction, the chief executive officer now owns 1,002,773 shares of the company’s stock, valued at $4,753,144.02. The trade was a 1.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 2,582,464 shares of company stock worth $4,950,344. Company insiders own 12.55% of the company’s stock.
Institutional Investors Weigh In On Zevia PBC
Wall Street Analyst Weigh In
Several research firms recently issued reports on ZVIA. The Goldman Sachs Group boosted their price target on Zevia PBC from $1.15 to $3.75 and gave the company a “neutral” rating in a research note on Tuesday, January 14th. Telsey Advisory Group reissued a “market perform” rating and issued a $4.00 target price on shares of Zevia PBC in a research report on Tuesday, January 14th.
Check Out Our Latest Research Report on Zevia PBC
Zevia PBC Company Profile
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.
Featured Stories
- Five stocks we like better than Zevia PBC
- What is a buyback in stocks? A comprehensive guide for investors
- DigitalOcean Rides Cloud Wave and AI Hype to Strong Earnings
- What is Insider Trading? What You Can Learn from Insider Trading
- Super Micro Computer Shares Surge on Compliance News
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.